- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01387633
Educational Intervention and Social Support in Diabetes Mellitus
July 1, 2011 updated by: University of Sao Paulo
The purpose of this study is to evaluate the impact of an educational program for people with diabetes mellitus based on the family social support.
Study Overview
Status
Unknown
Conditions
Detailed Description
H0: The person with diabetes who participates in the educational group whose family member/caregiver receives educational interventions hasn't greater glycemic control.
HA: The person with diabetes who participates in the educational group whose family member/caregiver receives educational interventions has greater glycemic control.
Study Type
Interventional
Enrollment (Anticipated)
264
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
São Paulo
-
Ribeirão Preto, São Paulo, Brazil, 14048-900
- Recruiting
- Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo
-
Contact:
- Ana Emilia Pace, Principal Investigator
- Phone Number: (55) 16 3602-3401
- Email: aepace@eerp.usp.br
-
Principal Investigator:
- Ana Emilia Pace, Principal Investigator
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- People with DM2
- Both sexes
- Minimum age of 40 years
- Able to dialogue
- Lack of complications in advanced
Exclusion Criteria:
- Hemodialysis treatment
- Amaurosis
- Sequelae of Stroke and/or Heart Failure
- Previous amputations at any level of the lower limb
- Active ulcer in the lower limbs
- People in wheelchairs and/or litter
- People with limited understanding of the instruments due to cultural factors
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Educational intervention through telephone contact
Educational intervention for family members/caregivers of people with diabetes mellitus through telephone contact
|
For family members/caregivers: telephone contacts will be conducted in day and time which family member/caregiver prefers, and he/she may make collect calls to the researcher always he/she judges it necessary during the period of study.
Phone contacts will be recorded to ensure the registration of orientation given, using a digital phone recorder PCTEL.
And they will be arranged with the technique of motivational interviewing that includes the skills to ask, listen and inform.
For this, protocols based on these skills, which the covered topics will be those worked in group sessions through Diabetes Conversation Maps.
Voice quality related to the tone, volume and clarity as well as the skills and strategies to listen to the interviews will be worked under the guidance of an audiologist
|
Active Comparator: Educational intervention group
Educational intervention group for people with diabetes through Diabetes Conversation Maps.
|
For people with diabetes mellitus: educational interventions will be conducted in accordance with the assumptions of the Social Cognitive Theory, through Diabetes Conversation Maps , whose use is consistent with this theory (ADA, 2007).
Diabetes Conversation Maps are a tool which involves people in the learning process about the disease, to make them able to process information more effectively and use them in making daily decisions in the management of diabetes mellitus (DM).
It is recommended that this tool is used in small groups of three to ten people, in order to provide dynamic discussions among the participants (ADA, 2007).
Currently, the maps that cover the following learning contexts: How the Body and Diabetes Work, Healthy Eating and Physical Activity, and Medication Treatment and Monitoring of Blood Glucose; Achieving the Goals with the Insulin and Weather Map of Diabetic Foot are available for the Brazilian Portuguese language.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
glycated hemoglobin
Time Frame: 21 mounths
|
21 mounths
|
fasting plasma glucose
Time Frame: 21 mounths
|
21 mounths
|
triglycerides
Time Frame: 21 mounths
|
21 mounths
|
total cholesterol and fractions
Time Frame: 21 mounths
|
21 mounths
|
microalbuminuria
Time Frame: 21 mounths
|
21 mounths
|
urea
Time Frame: 21 mounths
|
21 mounths
|
creatinine
Time Frame: 21 mounths
|
21 mounths
|
body mass index
Time Frame: 21 mounths
|
21 mounths
|
waist circumference
Time Frame: 21 mounths
|
21 mounths
|
blood pressure
Time Frame: 21 mounths
|
21 mounths
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Perceived Self-Efficacy: Diabetes Management Self-efficacy Scale for Patients with Type 2 Diabetes Mellitus
Time Frame: 21 mounths
|
21 mounths
|
Knowledge about diabetes mellitus: Diabetes Mellitus knowledge (DKN-A)
Time Frame: 21 mounths
|
21 mounths
|
Adherence to medication treatment: Self-Reported Measure of Medication Adherence (Measure of Treatment Adherence - MTA)
Time Frame: 21 mounths
|
21 mounths
|
Adherence to self care: Summary of Diabetes Self-Care Activities Questionnaire (SDSCA) ( Diabetes Self-Care Activities Questionnaire)
Time Frame: 21 mounths
|
21 mounths
|
Perception of stress: Perceived Stress Scale (Perceived Stress Scale)
Time Frame: 21 mounths
|
21 mounths
|
Ways of coping: Ways of Coping Scale (Ways of Coping Scale)
Time Frame: 21 mounths
|
21 mounths
|
Acceptance of Illness (Acceptance of Illness Scale)
Time Frame: 21 mounths
|
21 mounths
|
Perception of social support: The Social Support Network Inventory
Time Frame: 21 mounths
|
21 mounths
|
Self-monitoring of blood glucose
Time Frame: 21 mounths
|
21 mounths
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2011
Primary Completion (Actual)
June 1, 2011
Study Registration Dates
First Submitted
June 16, 2011
First Submitted That Met QC Criteria
July 1, 2011
First Posted (Estimate)
July 4, 2011
Study Record Updates
Last Update Posted (Estimate)
July 4, 2011
Last Update Submitted That Met QC Criteria
July 1, 2011
Last Verified
February 1, 2010
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- diabetes2011
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
Medical College of WisconsinMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical College of WisconsinMedical University of South Carolina; National Institute of Diabetes and Digestive...Active, not recruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical College of WisconsinNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States